Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(6.72) per share which beat the analyst consensus estimate of $(7.86) by 14.5 percent. This is a 27.35 percent increase over losses of $(9.25) per share from the same period last year. The company reported quarterly sales of $406.00 thousand which missed the analyst consensus estimate of $825.00 thousand by 50.79 percent. This is a 12.12 percent decrease over sales of $462.00 thousand the same period last year.